ALTSHULER DAVID (EVP, Global Research and CSO) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/26/2026ACC: 0000875320-26-000010
Officer· EVP, Global Research and CSO
Since Jun 2018
+11.19K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
11.19K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.87K
Price / share
—
Trade value
—
% of position
33.8%
1/22/2026
23.28K→31.15K
Common Stock
Direct
Shares
+3.33K
Price / share
—
Trade value
—
% of position
10.7%
1/22/2026
31.15K→34.48K
Total
Net shares
+11.19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | A · Award | +7.87K | — | — | 33.8% | 23.28K | 31.15K |
| Common Stock Direct | 1/22/2026 | A · Award | +3.33K | — | — | 10.7% | 31.15K | 34.48K |
| Total | +11.19K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported